Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001944477 | SCV002132641 | pathogenic | MHC class II deficiency | 2021-01-11 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Glu178*) in the RFXANK gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RFXANK are known to be pathogenic (PMID: 10803838, 16166641, 21908431). This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with RFXANK-related conditions. For these reasons, this variant has been classified as Pathogenic. |